Aerpio Pharmaceuticals, Inc. ARPO
52-week range unavailable
- Open
- 2.22
- Prev close
- 2.20
- Mkt cap
- 53.67M
- Vol
- 826.01K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.16
- High
- 2.30
- Forward P/E
- -1.21
- Beta
- 1.65
- Short ratio
- 1.81
- Inst. own
- 71.05%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 11, 2021
- 50-d avg
- 31.63
- 200-d avg
- 25.85
- 1y target
- 22.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for ARPO has not been loaded yet. Try again in a moment.
Altman Z-Score
0.18 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -6.7×
P/S 191×
P/B 10.0×
P/FCF -13.9×
EV/EBITDA -11.6×
EV/Sales 185×
FCF Yield -7.2%
Gross Margin 0.0%
Operating Margin -1601.1%
Net Margin -288.3%
ROE -15.1%
ROIC -83.9%
ROA -13.7%
Revenue -72.5%
Operating Income -69.6%
EPS (diluted) 86.0%
Free Cash Flow -60.1%
Current Ratio 10.3×
Quick Ratio 10.3×
Debt / Equity 0.0×
Net Debt / EBITDA 0.3×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31